SGEN

Seattle Genetics, Inc. News Headlines

$31.1
*  
0.14
0.45%
Get SGEN Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading SGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
5 Stocks Insiders Are Snapping Up: Seattle Genetics and More
12/24/2014 8:22:00 AM - TheStreet


Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?
12/23/2014 11:21:00 AM - Seeking Alpha


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Investopedia


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Zacks.com


Zacks' Bull Of The Day: Seattle Genetics
12/19/2014 9:14:00 AM - Seeking Alpha


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/19/2014 1:00:00 AM - Zacks.com


Seattle Genetics: Good Tech, But On The Wrong Path
12/18/2014 6:42:00 PM - Seeking Alpha


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/18/2014 1:00:00 PM - Investopedia


InsiderInsights.com Daily Round Up 12/17/14: HTZ, NAV, ENH, AIRT
12/18/2014 4:35:00 AM - Seeking Alpha


Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announces Positive Keytruda Study Results - Analyst Blog
12/12/2014 2:12:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS
12/11/2014 1:18:00 AM - Seeking Alpha


Seattle Genetics Is Offering Growth, For A Price
12/10/2014 1:06:00 PM - Seeking Alpha


Bristol-Myers Posts Positive Opdivo Hodgkin Lymphoma Data - Analyst Blog
12/8/2014 5:10:00 PM - Zacks.com


Merck's New Oncology Product Positive in Early Study - Analyst Blog
12/8/2014 3:10:00 PM - Zacks.com


The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
12/8/2014 7:15:00 AM - TheStreet


Seattle Genetics Announces Four-Year Survival Data From ADCETRIS Trial In ALCL
12/7/2014 12:17:00 PM - RTT News


Merck, Bristol Immunotherapies Expand Strongly Into Blood Cancers
12/6/2014 1:00:00 PM - TheStreet


Seattle Genetics, Takeda Report Phase3 AETHERA Clinical Trial Data From ADCETRIS
12/6/2014 11:20:00 AM - RTT News


Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
12/6/2014 11:00:00 AM - TheStreet


Seattle Genetics Larger Than S&P 500 Component Nabors Industries
11/25/2014 4:41:11 PM - BNK Invest


Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
11/21/2014 7:00:00 AM - Zacks.com


Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape
11/18/2014 8:30:00 AM - Zacks.com


Friday's ETF Movers: GDXJ, BBH
11/14/2014 2:59:06 PM - BNK Invest


InsiderInsights.com Daily Round Up 11/10/14: CHK, TWX, SGEN, PBFX
11/11/2014 3:29:00 AM - Seeking Alpha


3 Biotech Stocks to Watch in November
11/8/2014 11:03:17 AM - Motley Fool